Yu Liu

Prof. Yu Liu

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 December 2020 in Materials Letters
Verified
Journal Article
Closed access
KZKanghong Zhou
Kanghong Zhou
Yu LiuYu Liu
Yu Liu
JHJianyuan Hao
Jianyuan Hao


24 May 2022 in Chemosphere
Verified
Journal Article
Closed access
DGDongxu Gu
Dongxu Gu
Yu LiuYu Liu
Yu Liu
HZHongyu Zhu
Hongyu Zhu
YGYing Gan
Ying Gan
BZBiao Zhang
Biao Zhang
JHJianyuan Hao
Jianyuan Hao

1 January 2017 in Drug Delivery
Verified
Journal Article
Open access
XLXinyi Li
Xinyi Li
YYYuan Yang
Yuan Yang
YJYiping Jia
Yiping Jia
XPXuan Pu
Xuan Pu
TYTing Yang
Ting Yang
Yu LiuYu Liu
Yu Liu
Background: Multifunctional magnetic nanoparticles (MNP) have been newly developed for tumor-targeted drug carriers. To address challenges including biocompatibility, stability, nontoxicity, and targeting efficiency, here we report the novel drug deliverer poly(ethylene glycol) carboxyl–poly(ɛ-caprolactone) modified MNP (PEG–PCCL-MNP) suitable for magnetic targeting based on our previous studies. Methods: Their in vitro characterization and cytotoxicity assessments, in vivo cytotoxicity assessments, and antitumor efficacy study were elaborately investigated. Results: The size of PEG–PCCL-MNP was 79.6 ± 0.945 nm. PEG–PCCL-MNP showed little in vitro or in vivo cytotoxicity and good biocompatibility, as well as effective tumor-specific cell targeting for drug delivery with the presence of external magnetic field. Discussion: PEG–PCCL-MNP is a potential candidate of biocompatible and tumor-specific targeting drug vehicle for hydrophobic drugs.